Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Guangnian Liu"'
Autor:
Fusheng Zhang, Yongsu Ma, Dongqi Li, Jianlei Wei, Kai Chen, Enkui Zhang, Guangnian Liu, Xiangyu Chu, Xinxin Liu, Weikang Liu, Xiaodong Tian, Yinmo Yang
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-32 (2024)
Abstract Metabolic reprogramming provides tumors with an energy source and biofuel to support their survival in the malignant microenvironment. Extensive research into the intrinsic oncogenic mechanisms of the tumor microenvironment (TME) has establi
Externí odkaz:
https://doaj.org/article/39bb2397a0014455aa69c3ece416888d
Autor:
Xinxin Liu, Zhihua Huang, Qiuzheng Chen, Kai Chen, Weikang Liu, Guangnian Liu, Xiangyu Chu, Dongqi Li, Yongsu Ma, Xiaodong Tian, Yinmo Yang
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-14 (2024)
Abstract The mechanism of hypoxia in chemoresistance of pancreatic ductal adenocarcinoma (PDAC) remains elusive. In this study, we revealed the essential role of miR-485-3p in PDAC, particularly its impact on cancer stemness and gemcitabine resistanc
Externí odkaz:
https://doaj.org/article/bb460b7e274246b7a6971b64a36a96f5
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionProphylactic intra-peritoneal drainage has been considered to be an effective measure to reduce postoperative complications after pancreatectomy. However, routinely placed drainage during abdominal surgery may be unnecessary or even harmf
Externí odkaz:
https://doaj.org/article/ae3fca5a39e6481abb9c3b279b38d3ba
Publikováno v:
International journal of surgery (London, England). 90
Parecoxib, a selective cyclooxygenase-2 inhibitor, is a potential alternative analgesic to reduce opioid consumption after Pancreaticoduodenectomy (PD). Further, the safety and efficacy of long-term use of parecoxib for patients after PD remain a maj
Publikováno v:
Journal of Biomaterials and Tissue Engineering. 6:370-376
Publikováno v:
International Journal of Gerontology; 2021, Vol. 15 Issue 1, p82-83, 2p